
New Delhi, April 4, 2026 — OpenAI, the artificial intelligence powerhouse behind ChatGPT, announced a significant restructuring of its executive suite on Saturday. The move is headlined by Fidji Simo, the company’s CEO of AGI (Artificial General Intelligence) Development, who is taking an extended medical leave to manage a chronic health condition.
The leadership changes come at a pivotal moment for the company, which recently secured a $122 billion funding round at a staggering $852 billion valuation, fueled by rumors of a looming initial public offering (IPO).
Simo, who joined OpenAI in 2025 after a successful tenure as CEO of Instacart and a decade-long run at Meta, informed staff via an internal memo that her battle with Postural Orthostatic Tachycardia Syndrome (POTS)—a neuroimmune disorder she was diagnosed with in 2019—has reached a critical point.
“For my entire time here, I’ve postponed medical tests and new therapies to stay completely focused on the job,” Simo wrote. “It’s now clear that I’ve pushed a little too far and I really need to try new interventions to stabilize my health.”
Simo has been a central architect in OpenAI’s recent strategy to “de-clutter” its product line, moving away from experimental “side quests” to focus on a unified “Super App” that integrates chatbot functionality, web browsing, and coding tools.
In Simo’s absence, OpenAI President and co-founder Greg Brockman will step in to oversee the product organization. However, the reshuffle extends beyond Simo’s leave:
Industry analysts view this “C-suite overhaul” as a move to professionalize and stabilize the company’s operations as it eyes the public markets. With nearly 1 billion global users and an aggressive push into enterprise software and advertising, OpenAI is under pressure to prove it has a sustainable management structure.
Despite the temporary absence of Simo, a spokesperson for OpenAI emphasized the company’s momentum:
“We have a strong leadership team focused on our biggest priorities… We’re well-positioned to keep executing with continuity.”
The transitions mark a more human-centric approach to leadership at the tech giant, acknowledging the personal health battles of its top executives while maintaining a breakneck pace of AI development.